The impact of fluorescein-guided technique in the surgical removal of CNS tumors in a pediatric population: results from a multicentric observational study.
Surgery has a fundamental role in Central Nervous System (CNS) tumors in the pediatric population, as aggressive resection correlates with prognosis. Due to its accumulation in areas with damaged blood brain barrier, sodium fluorescein (SF) could be a valid tool to improve the extent of resection in tumors enhancing at pre-operative MRI. This study is aimed to systematically assess the utility of SF in a pediatric population. Patient data were collected in two Centers, one in Italy and the other in Germany. At the induction of anesthesia, SF was administered intravenously (5 mg/kg). Surgery was performed using a YELLOW560 filter. Fluorescence intensity was graduated as bright, moderate or absent based on surgeon's opinion; furthermore, SF use was judged as helpful, not helpful or not essential in tumor removal. 24 patients for 27 surgical procedures were identified. In 21/27 (77.8%) procedures fluorescence was reported as bright or moderate, in 2/27 (7.4%) absent and in 4/27 (14.8%) data were unavailable. Intraoperative fluorescence was reported in 21/25 (84%) surgeries whose corresponding pre-operative MRI had shown contrast enhancement. In 14/27 (51.8%) surgical procedures SF was considered helpful; in 2/27 (7.4%) not helpful; in 7/27 (25.9%) not essential. In 4/27 (14.8%) data were unavailable. No adverse effect to SF was registered. SF could be considered a valid and safe tool to improve visualization of tumors enhancing at pre-operative MRI also in pediatric patients. Future prospective studies are needed to confirm these preliminary data.